SCHEMBL2656837

SCHEMBL2656837

COCC(C)Nc1nc(Oc2ccc(S(C)(=O)=O)cc2)cc(C(=O)O)n1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GCK P35557 13/20 0.43
KCNH2 Q12809 3/20 0.41
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
HCAR3 P49019 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ATM Q13315 1/20 0.38
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
KDR P35968 1/20 0.36
GPR119 Q8TDV5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2658382 0.82 GCK (0.51) GCKKCNH2HCAR3
SCHEMBL943938 0.82 GCK (0.46) GCKKCNH2
SCHEMBL2659560 0.82 GCK (0.45) GCKKCNH2HCAR3
SCHEMBL2657667 0.82 GCK (0.45) GCKKCNH2HCAR3
SCHEMBL945414 0.80 GCK (0.49) GCKKCNH2
SCHEMBL2658299 0.80 GCK (0.41) GCKKCNH2PTGS1PTGS2HCAR3
SCHEMBL2657829 0.76 GCK (0.49) GCKKCNH2
SCHEMBL945737 0.76 GCK (0.46) GCKKCNH2CYP2C9KDR
SCHEMBL943469 0.75 GCK (0.54) GCKKCNH2
SCHEMBL2656881 0.74 GCK (0.51) GCKKCNH2CDK1CDK2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245025-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-03 EP claimed
WO-2009106209-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-03 WO claimed
EP-2245025-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-03 EP disclosed
WO-2009106209-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-03 WO disclosed